RPSAP20: A Potential Drug Target and Biomarker (G127406)

Target Name: RPSAP20

NCBI ID: G127406

RPSAP20

Other Name(s): RPSA_1_53 | Ribosomal protein SA pseudogene 20 | ribosomal protein SA pseudogene 20

RPSAP20: A Potential Drug Target and Biomarker

RPSAP20 (RPSA_1_53) is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a part of the RPSA family of proteins, which are known for their role in regulating protein synthesis and degradation. RPSAP20 is of particular interest as a potential drug target or biomarker, due to its unique structure and the involvement of various diseases.

Structure and Function

The RPSA family of proteins consists of several isoforms, including RPSA1, RPSA2, RPSA3, and RPSA4. These proteins share a conserved catalytic core and a common transmembrane region, but differ in their N-terminus and other tail. RPSAP20 is a 21 kDa protein that is expressed in the brain, heart, and lungs, and is involved in the regulation of protein synthesis and degradation.

RPSAP20 is composed of a 166 amino acid chain that spans 5.3 kDa. It has a unique structure, with a 105 amino acid long N-terminus that is rich in conserved secondary structure elements, such as a 尾-sheet and a 纬-helix . The N-terminus of RPSAP20 contains a single transmembrane region that is rich in electrostatic potential and is involved in the protein-protein interaction that is critical for its function.

RPSAP20 is involved in the regulation of protein synthesis and degradation in various tissues of the body. One of its well-established functions is its role in the regulation of protein synthesis in the brain. RPSAP20 has been shown to play a critical role in the regulation of neurotransmitter synthesis and release, as well as in the regulation of synaptic plasticity.

In addition to its role in neurotransmission, RPSAP20 is also involved in the regulation of protein synthesis and degradation in the heart and lungs. Studies have shown that RPSAP20 is involved in the regulation of cardiac function, and that it plays a role in the regulation of lung function and fibrosis.

Drug Targeting and Biomarkers

RPSAP20 is a potential drug target due to its unique structure and the involvement of various diseases. The unique 尾-sheet and 纬-helix in the N-terminus of RPSAP20 make it a potential target for small molecules that can modulate its activity. Additionally, the N-terminus of RPSAP20 is involved in the regulation of protein synthesis and degradation, which makes it a potential target for drugs that can modulate the activity of enzymes involved in this process.

In addition to its potential as a drug target, RPSAP20 may also be a biomarker for various diseases. The regulation of protein synthesis and degradation is involved in the development and progression of many diseases, including neurodegenerative disorders, cancer, and cardiovascular disease. Therefore, RPSAP20 may be a useful biomarker for the diagnosis and treatment of these diseases.

Conclusion

RPSAP20 is a unique protein that is involved in the regulation of protein synthesis and degradation in various tissues of the body. Its unique structure and the involvement of various diseases make it a potential drug target and biomarker. Further research is needed to fully understand the role of RPSAP20 in the regulation of protein synthesis and degradation, as well as its potential as a drug target and biomarker.

Protein Name: Ribosomal Protein SA Pseudogene 20

The "RPSAP20 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPSAP20 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets